期刊文献+

铥激光剥橘式前列腺切除术治疗良性前列腺增生症的远期临床观察 被引量:12

Long-term clinical study of Thulium laser resection of prostate-tangerine technique in the treatment of begin prostatic hyperplasia
原文传递
导出
摘要 目的评估铥激光剥橘式前列腺切除术(TmLRP-TT)治疗良性前列腺增生症(BPH)的长期疗效与远期并发症。方法2004年11月至2009年12月,对348例于上海市第一人民医院行TmLRP—Tr的BPH患者进行回顾性研究,随访患者术后长期疗效,内容包括前列腺症状评分(IPSS)、生活质量评分(QOL)、最大尿流率(Qmax)、残余尿量(PVR),记录并分析术后远期并发症。结果手术4年后患者IPSS、QOL、Qmax、PVR均显著改善。相比术前,IPSS下降了70%(22.7±7.7与6.8±5.1),QOL评分下降了65%(4.3±0.7与1.5±1.0),PVR下降了83%(104.7±34.3)ml与(17.7±10.7)ml,Qmax提高了212%(6.0±2.6)ml/s与(18.7±4.6)ml/s。术后累积远期并发症发生率6.0%(21/348)。其中1.2%(4/348)的患者因BPH复发再次行TmLRP—TT,尿道狭窄和膀胱颈部挛缩的发生率分别为2.3%(8/348)及2.6%(9/348)。患者对手术效果总体满意率为93%。结论TmLRP—TT治疗BPH疗效持久,远期并发症少,手术效果令人满意。 Objective To evaluate the long-term efficacies and complications of thulium laser resection of prostate-tangerine technique (TmLRP-TY) in the treatment of benign prostatic hyperplasia (BPH). Methods From November 2004 to December 2009, a total of 348 BPH patients undergoing TmLRP-Tr at our hospital were evaluated retrospectively for long-term efficacies and complications. The follow-up data included international prostate symptom score (IPSS), quality of life score (QOL), maximum urinary flow (Qm=) and postvoid urinary residual (PVR). Results After 4 years, IPSS decreased 70% (22. 7 ±7. 7 vs 6. 8±5. 1), QOL decreased 65% (4. 3 ±0. 7 vs 1.5± 1.0), Qmax increased 212% (6. 0 ±2. 6 ml/s vs 18.7±4. 6 ml/s) and PVR decreased 83% (104. 7 ±34. 3 ml vs 17.7 ± 10. 7 ml). Cumulative incidences of long-term complications was 6.0% ( n = 21 ), including a second TmLRP-TT due to BPH recurrence (n = 4, 1.2% ) , urethral stricture ( n = 8, 2. 3% ) and bladder neck contracture ( n = 9, 2.6%). Overall, 93% were satisfied with surgical outcomes. Conclusion TmLRP-TT has excellent efficacies with a low rate of long-term complications. Most patients are satisfied with surgical outcomes.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第48期3857-3860,共4页 National Medical Journal of China
关键词 前列腺切除术 良性前列腺增生症 Prostatectomy Benign prostatic hyperplasia Thulium
  • 相关文献

参考文献3

二级参考文献18

  • 1Gilling P J, Cass CB, Malcolm AR, Fraundorfer MR. Combination holmium and Nd:YAG laser ablation of the prostate: initial clinical experience. J Endourol 1995; 9: 151-3.
  • 2Gilling P J, Cass CB, Cresswell MD, Malcolm AR, Fraundorfer MR. The use of the holmium laser in the treatment of benign prostatic hyperplasia. J Endourol 1996; 10: 459-61.
  • 3Fried NM. Potential applications of the erbium:YAG laser in endourology. J Endourol 2001; 15: 889-94.
  • 4Fried NM, Murray KE. High-power thulium fiber laser ablation of urinary tissues at 1.94μm. J Endourol 2005; 19: 25-31.
  • 5Fried NM. High-power laser vaporization of the canine prostate using a 110 W Thulium fiber laser at 1.91 μm. Lasers Surg Med 2005; 36: 52-6.
  • 6Xia S J, Zhuo J, Sun XW, Han BM, Shao Y, et al. Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 2008; 53: 382-9.
  • 7Gilling P. Holmium laser enucleation of the prostate (HoLEP). BJU Int 2008; 101: 131-42.
  • 8Bach T, Herrmann TR, Ganzer R, Burchardt M, Gross AJ. RevoLix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up. World J Urol 2007; 25: 257-62.
  • 9Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, et al. Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol 2008; 22: 1041-5.
  • 10Fried NM. High-power laser vaporization of the canine prostate using a 110 W Thulium fiber laser at 1.91 mum. Lasers Surg Med,2005,36:52-56.

共引文献159

同被引文献61

引证文献12

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部